--- title: "Artius II Acquisition - Unit | 10-Q: FY2025 Q1 EPS: USD -0.31" type: "News" locale: "en" url: "https://longbridge.com/en/news/239203506.md" datetime: "2025-05-07T21:19:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/239203506.md) - [en](https://longbridge.com/en/news/239203506.md) - [zh-HK](https://longbridge.com/zh-HK/news/239203506.md) generator: "portal-rs" --- # Artius II Acquisition - Unit | 10-Q: FY2025 Q1 EPS: USD -0.31 EPS: As of FY2025 Q1, the actual value is USD -0.31. ### Segment Revenue - **Units Sold**: 22,000,000 Units at $10.00 per Unit, generating gross proceeds of $220,000,000. ### Operational Metrics - **Net Loss**: - $5,068,049 for the three months ended March 31, 2025, primarily due to advisory fees of $6,000,000 and operating costs of $141,488, offset by interest income of $1,073,439. - **General and Administrative Costs**: $141,488 for the three months ended March 31, 2025. - **Advisory Fee**: $6,000,000 recorded as of February 14, 2025. ### Cash Flow - **Net Cash Used in Operating Activities**: - $518,215 for the three months ended March 31, 2025. - **Net Cash Used in Investing Activities**: - $220,000,000 due to investment of cash into Trust Account. - **Net Cash Provided by Financing Activities**: $220,874,341, including proceeds from sale of Units and Private Placement Units. ### Unique Metrics - **Interest Earned on Trust Account**: $1,073,439 for the three months ended March 31, 2025. ### Future Outlook and Strategy - **Core Business Focus**: The company plans to use funds from the Trust Account to complete a Business Combination, with the intention to use share capital or debt as consideration. - **Liquidity Concerns**: The company may need to raise additional capital through loans or investments from its Sponsor or third parties to meet working capital needs, raising substantial doubt about its ability to continue as a going concern. ### Related Stocks - [AACBU.US](https://longbridge.com/en/quote/AACBU.US.md) ## Related News & Research - [Oil set for second weekly rise as unsettled US-Iran war crimps supply](https://longbridge.com/en/news/296555193.md) - [IREN Just Passed Its Biggest AI Test as Microsoft and Nvidia Bet Billions](https://longbridge.com/en/news/296533962.md) - [Google Is Reportedly Working with AMD for Its New TPU. What This Means for AMD Stock.](https://longbridge.com/en/news/296528134.md) - [Trump Boosted INTC and DELL: Now He Says ‘Do Magnets’—Are MP and USAR Stocks Next?](https://longbridge.com/en/news/296591886.md) - [Why Iovance Biotherapeutics Stock Hit 52-Week High](https://longbridge.com/en/news/296522969.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**